Seven Mile Advisory’s AbbVie ABBV Stock Holding History

Seven Mile Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$488K	Sell	1,941 -367	-16%	-$79K	0.33%	64
2026 Q1	$502K	Sell	2,308 -1,158	-33%	-$257K	0.36%	56
2025 Q4	$792K	Sell	3,466 -2,179	-39%	-$496K	0.14%	81
2025 Q3	$1.31M	Buy	5,645 +2,363	+72%	+$481K	0.21%	69
2025 Q2	$609K	Buy	3,282 +266	+9%	+$49.4K	0.37%	47
2025 Q1	$632K	Buy	3,016 +239	+9%	+$46.5K	0.42%	41
2024 Q4	$493K	Buy	2,777 +102	+4%	+$18.8K	0.31%	59
2024 Q3	$528K	Buy	2,675 +522	+24%	+$97.4K	0.35%	55
2024 Q2	$369K	Buy	2,153 +41	+2%	+$6.79K	0.27%	75
2024 Q1	$385K	Buy	2,112 +115	+6%	+$19.8K	0.29%	72
2023 Q4	$309K	Sell	1,997 -79	-4%	-$11.5K	0.27%	84
2023 Q3	$309K	Buy	2,076 +354	+21%	+$52K	0.33%	74
2023 Q2	$232K	Buy	+1,722	New	+$253K	0.27%	91

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Seven Mile Advisory's ABBV Position: Q2 2026 in Review

Seven Mile Advisory reduced its AbbVie (ABBV) stake by 16% in Q2 2026, selling an estimated $79K and leaving 1,941 shares worth $488K. The position accounts for 0.33% of the portfolio, ranked #64.

Seven Mile Advisory first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.31M in Q3 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Seven Mile Advisory held 1,941 shares of AbbVie worth $488K as of Q2 2026.
Seven Mile Advisory sold 367 AbbVie shares in Q2 2026, an estimated $79K.
AbbVie made up 0.33% of Seven Mile Advisory's portfolio in Q2 2026, its #64 holding.
Seven Mile Advisory first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
Seven Mile Advisory's AbbVie position peaked at $1.31M in Q3 2025.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Seven Mile Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.